Hongyan Liu
Children's Hospital of Philadelphia(US)Wuhan University(CN)Renmin Hospital of Wuhan University(CN)University of Science and Technology Beijing(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Virus-based gene therapy research, Renal cell carcinoma treatment, Cancer-related molecular mechanisms research, Renal Diseases and Glomerulopathies
Most-Cited Works
- → Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial(2021)205 cited
- → Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia(2021)180 cited
- → The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism(2013)152 cited
- → Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models(2018)150 cited
- → Cancer chemopreventive and therapeutic activities of red ginseng(1998)133 cited
- → Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy(2021)109 cited